Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px
Organisation › Details

Daiichi Sankyo (Group)

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimise growth opportunities across the value chain. *

 

Period Start 2005-09-28 merged
Product Industry pharmaceutical
     
Region Region Tokyo
  Country Japan
  City 103-8426 Tokyo
    Address record changed: 2008-12-07
     
Basic data Employees n. a.
     
    * Document for �About Section�: Daiichi Sankyo Co., Ltd.. (7/29/13). "Press Release: Daiichi Sankyo to Expand Its Collaborative Drug Discovery Program to Germany, Switzerland and Austria". Tokyo.
     
   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for Daiichi Sankyo (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px




» top